Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vaccinex Inc. (VCNX)

5.64   -0.5 (-8.14%) 02-14 16:00
Open: 5.89 Pre. Close: 6.14
High: 5.89 Low: 5.42
Volume: 21,048 Market Cap: 95M
Vaccinex, Inc., a clinical-stage biotechnology company, discovers and develops bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab that is in clinical development stage for the treatment of non-small cell lung cancer (NSCLC), osteosarcoma, melanoma, and Huntington's disease. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and potentially for other autoimmune disorders; VX25, a bi-specific natural killer T (NKT) cell stimulator, for the therapeutic application of NKT cell stimulation for cancer immunotherapy; BVX20, an investigational and humanized monoclonal antibody for the treatment of for multiple sclerosis. It has a clinical trial collaboration and supply agreement with Merck KGaA to test pepinemab in combination with avelumab checkpoint inhibitor in NSCLC p

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.899 - 5.94 5.94 - 5.972
Low: 5.318 - 5.371 5.371 - 5.411
Close: 5.565 - 5.638 5.638 - 5.695

Technical analysis

as of: 2020-02-14 4:33:30 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 11.01     One year: 14.28
Support: Support1: 4.88    Support2: 4.06
Resistance: Resistance1: 9.42    Resistance2: 12.23
Pivot: 6.74
Moving Average: MA(5): 6.21     MA(20): 6.43
MA(100): 5.68     MA(250): 5.59
MACD: MACD(12,26): 0.15     Signal(9): 0.31
Stochastic oscillator: %K(14,3): 10.93     %D(3): 15.80
RSI: RSI(14): 44.11
52-week: High: 12.23  Low: 3.77  Change(%): 23.1
Average Vol(K): 3-Month: 2482  10-Days: 2481

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
VCNX has closed above bottom band by 9.1%. Bollinger Bands are 38.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN )(announced early termination of waiting period for its proposed acquisition by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN )) Cidara Therapeutics Inc (NASDAQ: CDTX ) Cleveland BioLabs, Inc. (NASDAQ: CBLI )(saw a coronavirus-induced rally ) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY )(reacted to its Q3 results) Inovio Pharmaceuticals Inc (NASDAQ: INO )(announced Nevro Corp (NYSE: NVRO ) Oyster Point Pharma Inc (NASDAQ: OYST ) Quest Diagnostics Inc (NYSE: DGX ) Rapt Therapeutics Inc (NASDAQ: RAPT ) SI-Bone Inc (NASDAQ: SIBN ) Vaccinex Inc (NASDAQ: VCNX ) Vir Biotechnology Inc (NASDAQ: VIR ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 27) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Avanos Medical Inc (NYSE: AVNS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Correvio Pharma Corp (NASDAQ: CORV ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Kura Oncology Inc (NASDAQ: KURA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) MediciNova, Inc.

Vaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study
Vaccinex (VCNX) completes enrollment in a phase Ib/II study of its pipeline candidate pepinemab in combination with Bavencio for treating advanced non-small cell lung cancer.

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 14.86
Shares Float (M) 3.05
% Held by Insiders 25.48
% Held by Institutions 58.77
Shares Short (K) 69
Shares Short P. Month (K)

Stock Financials

EPS -2.820
Book Value (p.s.) -1.350
PEG Ratio
Profit Margin
Operating Margin -4775.04
Return on Assets (ttm) -105.2
Return on Equity (ttm) -245.8
Qtrly Rev. Growth 104.0
Gross Profit (p.s.) -0.021
Sales Per Share
EBITDA (p.s.) -2.288
Qtrly Earnings Growth
Operating Cash Flow (M) -32.47
Levered Free Cash Flow (M) -20.06

Stock Valuations

P/E -2.00
P/E Growth Ratio -0.05
P/BV -4.18
P/S 94.00
P/CF -2.58

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.